Considering a molecular clinical viewpoint, Relafen 750 (Naproxen) exhibits particular properties . It works primarily as a non-copyrightal medication , selectively inhibiting cyclooxygenase-2 (COX-2), an enzyme participating in prostaglandin production . This targeted inhibition results in diminished inflammation and pain , providing clinical adva